In this series, combination with the serum tumor marker levels may improve the diagnostic accuracy of PET/CT of multiple primary cancers, particularly for a number of suspected tumor patients with other highly specific biomarkers, such as prostate-specific antigen (PSA) and alpha-fetoprotein (AFP). The gene discussed is AFP; the disease is neoplasm.